![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 37, 28562-28568, September 15, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,From the Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201
Received for publication, April 12, 2000
| |
ABSTRACT |
|---|
|
|
|---|
The mechanism for coupling between
Ca2+ stores and store-operated channels (SOCs) is an
important but unresolved question. SOC-mediated Ca2+ entry
is complex and may reflect more than one type of channel and coupling
mechanism. To assess such possible divergence the function and coupling
of SOCs was compared with two other distinct yet related
Ca2+ entry mechanisms. SOC coupling in DDT1MF-2
smooth muscle cells was prevented by the permeant inositol
1,4,5-trisphosphate (InsP3) receptor blockers,
2-aminoethoxydiphenyl borate (2-APB) and xestospongin C. In contrast,
Ca2+ entry induced by S-nitrosylation and
potentiated by store depletion (Ma, H-T., Favre, C. J., Patterson,
R. L., Stone, M. R., and Gill, D. L. (1999)
J. Biol. Chem. 274, 35318-35324) was unaffected by 2-APB, suggesting that this entry mechanism is independent of InsP3 receptors. The cycloalkyl lactamimide,
MDL-12,330A (MDL), prevented SOC activation (IC50 10 µM) and similarly completely blocked
S-nitrosylation-mediated Ca2+ entry.
Ca2+ entry mediated by the TRP3 channel stably expressed in
HEK293 cells was activated by phospholipase C-coupled receptors
but independent of Ca2+ store depletion (Ma, H.-T.,
Patterson, R. L., van Rossum, D. B., Birnbaumer, L.,
Mikoshiba, K., and Gill, D. L. (2000) Science 287, 1647-1651). Receptor-induced TRP3 activation was 2-APB-sensitive and
fully blocked by MDL. Direct stimulation of TRP3 channels by the
permeant diacylglycerol derivative,
1-oleoyl-2-acetyl-sn-glycerol, was not blocked by 2-APB,
but was again prevented by MDL. The results indicate that although the
activation and coupling processes for each of the three entry
mechanisms are distinct, sensitivity to MDL is a feature shared by all
three mechanisms, suggesting there may be a common structural feature
in the channels themselves or an associated regulatory component.
Ca2+ signals control many cellular functions ranging
from short term responses such as contraction and secretion to longer
term regulation of cell growth and proliferation (1). Receptor-induced cytosolic Ca2+ signals are complex involving two closely
coupled components: rapid, transient release of Ca2+ stored
in the endoplasmic reticulum
(ER),1 followed by slowly
developing extracellular Ca2+ entry (1-5). G
protein-coupled receptors and tyrosine kinase receptors, through
activation of phospholipase C, generate the second messenger, inositol
1,4,5-trisphosphate (InsP3), which diffuses rapidly within
the cytosol to interact with InsP3 receptors on the ER that
serve as Ca2+ channels to release luminal stored
Ca2+ and generate the initial Ca2+ signal phase
(1, 3). The resulting depletion of Ca2+ stored within the
ER lumen serves as the primary trigger for a message, which is returned
to the plasma membrane resulting in the slow activation of
"store-operated" Ca2+ entry channels (2, 4-6). This
second Ca2+ entry phase of Ca2+ signals serves
to mediate longer term cytosolic Ca2+ elevations and
provides a means to replenish intracellular stores (2, 4). Whereas
receptor-induced generation of InsP3 and the function of
Ca2+ release channels to mediate the initial
Ca2+ signaling phase is well understood, the mechanism for
coupling ER Ca2+ store depletion with Ca2+
entry remains a crucial but unresolved question (4-6).
Direct coupling between ER and plasma membrane has been hypothesized
(7, 8), and evidence indicates that physical docking of ER with the
PM is involved in SOC activation (9-12). The mammalian TRP
family of receptor-operated ion channels appear to share some operational parameters with SOCs (13, 14). Kiselyov et al. (15, 16) provided evidence that activation of the human TRP3 channel
can result from an interaction with InsP3 receptors.
Indeed, it appears that activation and maintenance of endogenous
store-operated channels requires the InsP3 receptor (17).
However, whereas members of the TRP family of proteins appear widely
expressed (18, 19), their involvement in physiological store-operated Ca2+ entry remains uncertain (17, 20).
One complexity that hinders a unified understanding of store-operated
Ca2+ entry is the heterogeneous nature of the process among
different cell types. Although the Ca2+-selective current,
ICRAC, is operational in some cells, a number of distinct
store-operated currents of varying divalent cation selectivity have
been described (4, 5). Also, significant differences in the activation
and deactivation of store-operated Ca2+ entry have been
observed among different cells (4, 21-24). In recent work (23, 24), we
characterized a Ca2+ entry process activated by
S-nitrosylation that can be stimulated by depletion of
stores. In this report, we have compared the function and coupling of
store-operated Ca2+ entry with operation of TRP3 channels
and the S-nitrosylation-activated entry mechanism. The
results indicate that whereas clear differences exist in the activation
and coupling of these different entry mechanisms, there may
nevertheless be underlying structural and functional similarities.
Culture of Cells--
DDT1MF-2 smooth muscle cells
derived from hamster vas deferens were cultured in Dulbecco's modified
Eagle's medium supplemented with 2.5% calf serum as described
previously (25, 26); DC-3F Chinese hamster lung fibroblasts were
cultured in Measurement of Intracellular Calcium--
Cells grown on
coverslips for 1 day were transferred to Hepes-buffered Krebs medium
(107 mM NaCl, 6 mM KCl, 1.2 mM
MgSO4, 1 mM CaCl2, 1.2 mM KH2PO4, 11.5 mM
glucose, 0.1% bovine serum albumin, 20 mM Hepes-KOH, pH
7.4) and loaded with fura-2/AM (2 µM) for 10 min at
20 °C. Cells were washed and dye allowed to deesterify for a minimum
of 15 min at 20 °C. Approximately 95% of the dye was confined to
the cytoplasm as determined by the signal remaining after saponin
permeabilization (29, 30). Fluorescence emission at 505 nm was
monitored with excitation at 340 and 380 nm; Ca2+
measurements are shown as 340/380 nm ratios obtained from a groups of
10-12 cells. Details of these Ca2+ measurements were
described for DDT1MF-2 and (31) DC-3F cells (28) and the
T3-65 clone of HEK293 cells (17). Resting Ca2+ levels in
DDT1MF-2 cells were approximately 60-90 nM,
25-50 nM in DC-3F cells, and 50-100 nM in
HEK293 cells. All measurements shown are representative of a minimum of
three, and in most cases, a larger number of independent experiments.
Materials and Miscellaneous Procedures--
GEA3162 was from
Alexis Corporation, San Diego, CA. Thapsigargin (TG) was from LC
Services, Woburn, MA. Fura-2/acetoxymethylester was from Molecular
Probes, Eugene, OR. Xestospongin C was from I. Pessah, University of
California, Davis, CA), and 2-APB was from K. Mikoshiba, University of
Tokyo. MDL-12,330A was from Calbiochem. OAG and other compounds were
from Sigma.
We recently revealed that the activation of store-operated
Ca2+ channels in the plasma membrane likely requires a
physical interaction between the plasma membrane and endoplasmic
reticulum membrane (9). In addition, evidence indicates that the
InsP3 receptor is an essential component mediating the
coupling between store emptying and the activation of store-operated
channels (17). However, the activation of store-operated entry has
proven an elusive process and the functional properties of
store-operated channels can differ significantly between cell types. We
determined recently that in some but not all cells, Ca2+
entry can be directly activated through a process mediated by S-nitrosylation (23). Since store depletion potentiates this process (23, 24), it was important to assess further its relationship to store-operated Ca2+ entry.
A useful tool in elucidating the coupling mechanism for SOC activation
has been the cell-permeant InsP3 receptor blocker, 2-aminoethoxydiphenyl borate (2-APB) (17, 32, 33). In HEK293 cells
2-APB not only blocks receptor-induced Ca2+ release from
stores but also blocks store-operated Ca2+ entry activated
in response to depletion of pools with either receptor agonists or
sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump
inhibitors. In addition, 2-APB blocks receptor-induced activation of
TRP3 channels in HEK293 cells stably transfected to express TRP3
channels (17). To investigate the role of InsP3 receptors
in S-nitrosylation-mediated Ca2+ entry,
experiments were first undertaken to assess the action of 2-APB on
Ca2+ regulation in the DDT1MF-2 cell line in
which there is a large Ca2+ entry response to
S-nitrosylating conditions (23, 24). The action of 2-APB on
store-operated Ca2+ entry in fura-2-loaded
DDT1MF-2 cells is revealed in Fig.
1. Application of 1 µM
thapsigargin induced a rapid release of Ca2+ from stores
observed as a sharp rise in cytosolic Ca2+, followed by a
second more slowly developing peak of cytosolic Ca2+ (Fig.
1A). The latter peak represents Ca2+ entry and
was eliminated when the medium was replaced with nominally Ca2+-free external medium (Fig. 1B). Upon
readdition of external Ca2+, entry of Ca2+ was
transiently very large, representing the familiar "overshoot" response for store-operated Ca2+ channels (22, 28). If 75 µM 2-APB was added together with thapsigargin, it had
little effect on the Ca2+ release component but completely
blocked the Ca2+ entry component of the cytosolic
Ca2+ signal response to thapsigargin (Fig. 1C).
When 2-APB was added during the entry phase, it rapidly blocked entry
(Fig. 1D). 2-APB is an effective cell-permeant inhibitor of
the InsP3 receptor (17, 32, 33), and the blockade of
store-operated Ca2+ entry caused by 2-APB appears to
reflect the involvement of the InsP3 receptor in mediating
and maintaining store-operated Ca2+ entry in
DDT1MF-2 cells as in HEK293 cells (17). Another
InsP3 receptor blocker, the natural product, xestospongin
C, also blocks InsP3 receptor function (34) and similarly
blocked Ca2+ entry in DDT1MF-2 cells (Fig.
1E). Although xestospongin C completely blocked entry, its
action was much slower than 2-APB and required 20 min of treatment for
a full effect. Both xestospongin C and 2-APB appear to have a similar
mode of action. Evidence indicates that both molecules block the
InsP3 receptor but do not interact directly with the
InsP3 binding site (32, 34). Certainly, the similarity of
action of the two molecules on Ca2+ entry provides good
evidence that the action of both agents is related to their interaction
with the InsP3 receptor. However, the similarity of action
of two molecules with apparently rather different structures was
curious (see Fig. 1). We undertook mass spectral analysis of 2-APB and
determined that the predominant species of 2-APB under the conditions
used appears to be a dimeric structure of molecular mass 450 Da,
most likely involving the coordinate covalent bond shown in Fig.
1.2 This is a significantly
more hydrophobic species than the monomer and likely accounts for the
extremely rapid action of 2-APB in blocking InsP3 receptors
(17). Also, the dimeric form of 2-APB does share some distant
structural similarity to the xestospongin C molecule and may explain
the similarity in their mode of action.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-modified Eagle's medium supplemented with 5%
heat-inactivated fetal bovine serum as described previously (27, 28).
The T3-65 clonal line of HEK293 cells were cultured as described
recently (17).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 1.
Store-operated Ca2+ entry into
DDT1MF-2 cells is inhibited by 2-APB and xestospongin
C. Cytosolic Ca2+ was measured in fura-2-loaded
DDT1MF-2 cells as described under "Experimental
Procedures." Standard conditions included 1 mM
Ca2+ in the external medium; medium was replaced with
nominally Ca2+-free medium (
Ca2+) for the
times shown (bars). A, Ca2+ pools
were depleted by adding the Ca2+ pump blocker, thapsigargin
(TG) at 1 µM (arrow) followed by
transient Ca2+ removal. B, 1 µM TG
was added (arrow) in the absence of Ca2+,
followed by the readdition of standard Ca2+. C,
1 µM TG (arrow) was added together with 75 µM 2-APB (bar) maintained through
Ca2+ removal and readdition. D, Ca2+
pools were released with 1 µM TG, and 75 µM
2-APB was added later (bar). E, cells were
pretreated for 20 min with 25 µM xestospongin C
(xestC) in the presence of Ca2+ followed by 1 µM TG addition (arrow) and removal/readdition
of Ca2+. Inset, three structures are presented:
the monomer form of 2-APB (upper), the spectrally determined
dimerized form of 2-APB (middle), and xestospongin C
(lower).
The question of the relationship between
S-nitrosylation-induced Ca2+ entry and
store-operated Ca2+ entry was investigated using 2-APB. The
typical operation of Ca2+ entry activated by these two
processes is shown in Fig. 2A.
Release and entry in response to thapsigargin application are shown,
followed by induction of a Ca2+ overshoot by subsequent
transient Ca2+ removal. The overshoot of Ca2+
entry rapidly diminished due to desensitization of the channel (9, 24).
However, application of the lipophilic NO donor, GEA3162, induced a
rapid and large further increase in Ca2+. This response is
typical of the action of a number of different NO donors and alkylators
(23) and is believed to reflect a Ca2+ entry mechanism
activated through S-nitrosylation (23, 24). The
Ca2+ entry response to GEA3162 is considerably potentiated
by store depletion (23)and also by transient removal and readdition of extracellular Ca2+ (24). As seen in Fig. 2B, a
large and rapid entry of Ca2+ occurs upon removal and
readdition of Ca2+ in the presence of GEA3162 even though
stores had not been emptied. The stimulation of NO donor-induced
Ca2+ entry by both pool emptying and transient
Ca2+ removal has suggested an intriguing similarity with
store-operated Ca2+ channels (23, 24). However, there is an
important difference between the two entry mechanisms. Thus, while the
InsP3 receptor antagonist, 2-APB, completely blocks
store-operated entry, it has little effect on the action of GEA3162
(Fig. 2C). In this experiment, 2-APB blocked the
Ca2+ entry in response to store emptying with thapsigargin
and the subsequent overshoot of Ca2+ entry, however,
application of GEA3162 still gave a rapid and large Ca2+
entry response in the continued presence of 2-APB (Fig. 2C). Moreover, 2-APB did not diminish the GEA3162-dependent
entry of Ca2+ following removal and readdition of
Ca2+ (Fig. 2D).
|
These results suggested a fundamental difference between the function
of SOCs and the NO donor-induced entry mechanism. Activation of SOCs
appears to require the InsP3 receptor as a coupling
intermediary. In contrast, the action of GEA3162 might be consistent
with the NO donor having a direct effect on a channel in the membrane. The results are also consistent with the effects of calyculin A-induced
rearrangement of cortical actin, which prevents SOC activation by
separating ER and plasma membrane (9) but does not prevent the action
of GEA3162 (24). We considered it important to assess whether GEA3162
works directly to modify a channel or whether other intermediaries or
second messengers might be involved. Our previous work indicated that
the NO donor was functioning independently of cyclic GMP (23). In
evaluating the possible involvement of cyclic AMP we utilized a number
of different adenylyl cyclase modifiers including the cycloalkyl
lactamamide, MDL-12330A, which has been utilized widely as an
irreversible adenylyl cyclase inhibitor (35-37). Surprisingly, as
shown in Fig. 3, this agent was effective
in blocking store-operated Ca2+ entry in a number of
different cell types. In DDT1MF-2 cells, 100 µM MDL almost completely blocked both the entry phase
following thapsigargin treatment and the subsequent overshoot response
(Fig. 3, A-C). Very similar results were obtained in the
DC-3F fibroblast line (Fig. 3, D-F) and in HEK293 cells
(not shown). In the A7r5 smooth muscle line in which entry of
Ca2+ is observed as a larger and more sustained increase in
cytosolic Ca2+ following store emptying, the action of MDL
was again to completely block Ca2+ entry (Fig. 3,
G-I). In each cell line, the action of MDL appeared to be
specifically on Ca2+ entry with little effect on basal
Ca2+ levels or the size of releasable pools.
|
To evaluate the effect of MDL on store-operated Ca2+ entry
we wished to know whether its actions were related to adenylyl cyclase activity. We therefore assessed the effects of another permeant adenylyl cyclase inhibitor, 2',5'-dideoxyadenosine (DDA). At 100 µM, DDA had no significant effect on store-operated
Ca2+ entry (Fig.
4A). In other experiments (not
shown), addition of the permeant cyclic AMP analogues, 8-bromo-cyclic
AMP or 8-CPT-cyclic AMP, at concentrations up to 1 mM, either alone or in combination with MDL, had no
significant effect on Ca2+ entry. Also, the adenylyl
cyclase activator, forskolin, alone or in combination with the
phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, either with
or without MDL, did not influence Ca2+ entry. The effects
of MDL on adenylyl cyclase activity are reported to be irreversible
(35). However, experiments revealed that the blocking action of MDL on
Ca2+ entry could be readily reversed. When cells were
treated with 100 µM MDL for 5 min followed by a wash in
MDL-free medium for 10 min, store-operated Ca2+ entry
returned (data not shown). After blocking Ca2+ entry
induced by thapsigargin with MDL, Ca2+ entry returned
within 3 min of washing away MDL (Fig. 4B). In this
experiment, 100 µM MDL was added acutely with
thapsigargin, and the entry phase of the Ca2+ response was
eliminated. Both MDL and Ca2+ were removed for a 3-min
period; upon Ca2+ readdition, a normal overshoot response
was obtained. In combination, these results indicate that the
inhibition of store-operated Ca2+ entry with MDL did not
appear related to effects on either adenylyl cyclase activity or the
levels of cyclic AMP in cells.
|
The above actions of MDL were to block Ca2+ entry in response to store emptying with the Ca2+ pump blocker thapsigargin. Physiologically, store emptying does not occur through pump blockade. Therefore, it was important to assess the actions of MDL on Ca2+ entry in response to agonist-induced Ca2+ release. Generation of InsP3 as a result of phospholipase C-coupled receptor activation results in a rapid release of Ca2+ from stores. Efficient receptor desensitization results in short-lived InsP3 increases, hence store emptying and subsequent Ca2+ entry can be very transient (9, 17). If agonist treatment is undertaken in the absence of external Ca2+, entry is prevented and stores remain at least partially empty (9). As shown in Fig. 4C, addition of bradykinin in the absence of external Ca2+ induced a rapid release of Ca2+. Readdition of Ca2+ resulted in store-operated Ca2+ entry albeit smaller than that observed following the irreversible pump blockade induced by thapsigargin. Addition of MDL 1 min prior to bradykinin addition completely blocked this entry response (Fig. 4D). Significantly, MDL had no effect on agonist-induced Ca2+ release, indicating that it does not inhibit receptor-activated phospholipase C activation nor does is alter the function of InsP3 receptors to release Ca2+. Moreover, since MDL does not change basal levels of Ca2+ in cells or the release of Ca2+ in response to agonists or thapsigargin, this indicates that it does not alter cellular Ca2+ homeostasis maintained by Ca2+ pumps or the size or operation of Ca2+ stores.
We examined the kinetics of MDL's inhibitory effect on store-operated
Ca2+ entry in more detail. Ca2+ entry following
thapsigargin addition was compared in the presence of different MDL
levels added 5 min before thapsigargin. The responses in the presence
of 0, 10, and 100 µM MDL are shown in Fig.
5, A, B, and
C, respectively. The concentration dependence of the action
of MDL on the component of Ca2+ entry induced by
thapsigargin is shown in Fig. 5D. Significant inhibition was
observable with 1 µM MDL, and its effects were half-maximal at approximately 10 µM. This may be
significantly different to the sensitivity of adenylyl cyclase to MDL,
the IC50 of which is reported as 250 µM (35).
The time dependence for the action of MDL was assessed by examining the
overshoot response which occurs almost instantaneously after
Ca2+ readdition (Fig. 5E). The effect of 100 µM MDL added simultaneously with Ca2+ was not
observable until approximately 1 min after addition (Fig. 5F). Added 1 min prior to Ca2+ readdition, the
action of MDL was substantial but not full (Fig. 5G). The
action of MDL was almost complete when added for 10 min before
Ca2+ readdition (Fig. 5H). Therefore, the effect
of MDL is slightly different from that of 2-APB, which blocks
store-operated Ca2+ entry extremely rapidly (Fig.
1C).
|
Returning to the question of Ca2+ entry activated in
response to S-nitrosylation, MDL is clearly an effective
blocker of this entry response as well. Following store emptying with
thapsigargin, the large increment in Ca2+ entry induced by
GEA3162 (Fig. 6A) was
completely blocked by the inclusion of 100 µM MDL added
at the same time as thapsigargin (Fig. 6B). In this
experiment, MDL had also almost completely blocked store-operated
Ca2+ entry. If, after pool emptying, MDL was added
simultaneously with GEA3162, the increase in entry was rapidly
attenuated, and only a small transient increase in entry was seen (Fig.
6C). If, after pool emptying, MDL was added without GEA3162,
the store-operated entry was inhibited with a similar time dependence
(Fig. 6D). In normal store-filled cells, the entry of
Ca2+ observed following GEA3162 addition without external
Ca2+ and subsequent readdition of Ca2+ (Fig.
6E) was completely blocked by inclusion of MDL in the medium (Fig. 6F). The concentration dependence of the blocking
action of MDL on GEA3162-induced entry (not shown) revealed a very
similar sensitivity to that of store-operated Ca2+ entry,
with an IC50 of approximately 10 µM.
|
These results indicate that the blocking action of MDL on
store-operated Ca2+ entry and entry activated in response
to the NO donor, GEA3162, is very similar. We and others (13-15, 17)
have recently determined that some functional parameters of
store-operated Ca2+ channels are shared with members of the
TRP family of proteins. Receptor-induced activation of the human TRP3
channel stably expressed in HEK293 cells appears to have a requirement
for the InsP3 receptor (17), in agreement with earlier data
(15). This requirement for the InsP3 receptor appears to be
the same for store-operated channels (17). However, the two channels
differ with respect to one important parameter, that is, their
relationship to store emptying. Thus, we and others (17, 18,
38-40) did not observe any correlation between the operation of TRP3
channels and the emptying of stores, indicating that activation of the
TRP3 channel, although requiring the InsP3 receptor, occurs
through a more direct coupling process (17). In view of this
difference, assessing any pharmacological relationship between the
action of TRP3 channels and SOCs was important. As shown in Fig.
7, MDL clearly blocked TRP3 activity. In
the T3-65 clonal HEK293 line stably expressing TRP3 channels, the
operation of these channels could be specifically observed by examining
Sr2+ entry (17). Thus, although the cells also contain
SOCs, the latter do not allow passage of Sr2+ under these
conditions. Therefore, Sr2+ entry following PLC-coupled
receptor agonist activation was a reliable means for independently
assessing only function of TRP3 channels (17). As shown in Fig.
7A, application of carbachol in these cells induced a
transient release of Ca2+ from stores in the absence of
external Ca2+. Application of external Sr2+
resulted in a rapid entry of Sr2+ mediated by the TRP3
channel. If MDL was applied at the start of the trace, the
agonist-induced release of Ca2+ was essentially unaffected,
whereas the entry of Sr2+ was completely eliminated (Fig.
7B). Added during the sustained entry of Sr2+
mediated by the TRP3 channel, MDL terminated the channel activity (Fig.
7C). If MDL was added simultaneously with Sr2+
addition, there was a brief increase in Sr2+ entry which
disappeared shortly after (Fig. 7D). Therefore, it is clear
that MDL blocks receptor-induced activation of the TRP3 channel and
that sensitivity to MDL is a property shared by TRP3 and store-operated
Ca2+ entry channels.
|
In a recent report, Hofmann et al. (40) revealed that
certain TRP channels, including the TRP3 channel, could be directly activated by diacylglycerol, and this effect was quite independent of
protein kinase C activation. The conclusion from this study was that
DAG, and not InsP3, was the PLC-derived product responsible for agonist-induced activation TRP3 channels (40). However, our results
indicated that TRP3 channels could be activated by both
PLC-derived products (17). As shown in Fig.
8A, the membrane permeant DAG
analogue, OAG, induced a clear activation of the TRP3 channel. This
property of the TRP3 channel is quite distinct from SOC, which is
insensitive to DAG analogues (17). The InsP3 receptor
blocker 2-APB did not alter OAG-induced activation of TRP3 channels
(Fig. 8B), suggesting that DAG may activate the channel
directly and independently from the InsP3 receptor (17). In
contrast, inclusion of MDL in the medium prior to OAG addition almost
completely eliminated the OAG response (Fig. 8C). This provides useful further evidence that OAG is indeed acting on the TRP3
channel. When added simultaneously with OAG, the action of MDL was
significantly diminished (Fig. 8D), that is, it was less
effective in blocking. If MDL was added after OAG-induced TRP3
activation the inhibitory action of MDL was yet further reduced (not
shown). The results suggest that both MDL and OAG may directly modify
the TRP3 channel. Considering the diminished ability of MDL to reverse
prior activation by OAG (in contrast to its very rapid termination of
TRP3 activated by carbachol, as shown in Fig. 7C), it is
possible that the diacylglycerol and MDL compete for a common site of
action.
|
Overall, the results presented here provide some interesting
similarities and differences in the operation of three distinct but
related Ca2+ entry mechanisms. The coupling mechanism by
which store-operated Ca2+ entry is activated has proven
elusive. Most likely, the process involves "conformational
coupling" between components of the ER and plasma membrane (7-9),
and it appears that the InsP3 receptor is a required ER
component mediating the coupling process (15, 17). A significant
problem in assessing operation of store-operated entry is its apparent
heterogeneity between cells perhaps indicating that a number of related
channels can be store-coupled. Here we have compared endogenous
store-operated Ca2+ entry with two other distinct but
related entry mechanisms. The TRP3-mediated Ca2+ entry
operates independently of stores, yet its activation appears to require
the InsP3 receptor. The
S-nitrosylationdependent entry mechanism is
potentiated by store emptying but appears to reflect a direct
activation process not mediated or maintained by the InsP3
receptor; this may indicate that coupling between stores and entry
channels is not always mediated by the InsP3 receptor. Whereas these distinctions in coupling exist, a common feature of all
three entry mechanisms is their sensitivity to the cycloalkyl lactamimide blocker, MDL-12,330A. Whereas sensitivity in the 10 µM range may not indicate a high affinity interaction,
the similarity of sensitivity of the entry mechanisms to MDL is a
significant finding. It should also be considered that, thus far, few
reliable direct modifiers of store-operated entry have been identified. The econozoles, including SKF93635, have been utilized as blockers (42); however, our analysis of econozole action indicates great variation in their effectiveness between different cell types. In some
cells SKF96365 may block in the high micromolar range (28), whereas in
others there is little effect on Ca2+ entry and/or spurious
changes in fluorescence.3 The
reason for this variation is unclear but may reflect differences in
channel subtypes and/or coupling state. In contrast, the action of MDL
is very reliable between cells. Interestingly, there have been reports
of direct actions of MDL in the low micromolar range on
voltage-operated Ca2+ channels (41, 43, 44),
suggesting that there may be some wider structural relationship between
Ca2+ entry channels. Any relationship between these entry
mechanisms might be further elucidated from examination of the actions
of molecules structurally related to MDL.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Cecile Favre and Dr. Carmen Ufret-Vincenty for help in the early part of these studies, Dr. Katsuhiko Mikoshiba for supplying 2-APB, Dr. Lutz Birnbaumer for providing the transfected HEK293 cells, Dr. David Christianson for helpful structural advice, and Dr. Hee-Yong Kim for mass spectral analysis of the 2-APB molecule.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant HL55426, a fellowship from the Interdisciplinary Muscle Training Program (to R. L. P.), and a fellowship (to H.-T. M.) from the American Heart Association, Maryland Affiliate.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The contribution of these two authors was equal.
§ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene St., Baltimore, MD 21201. Tel.: 410-706-2593 (office) or -7247 (laboratory); Fax: 410-706-6676; E-mail, dgill@umaryland.edu.
Published, JBC Papers in Press, June 30, 2000, DOI 10.1074/jbc.M003147200
2 D. L. Gill and H.-Y. Kim, unpublished observations.
3 R. L. Patterson and D. L. Gill, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ER, endoplasmic
reticulum;
InsP3, inositol 1,4,5-trisphosphate;
NO, nitric
oxide;
fura-2/AM, fura-2 acetoxymethylester;
GEA3162, (5-amino-3-(3,4-dichlorophenyl)1,2,3,4-oxatriazolium);
MDL-12, 330A,
cis-N-(2-phenylcyclopentyl)azacyclotridec-1-en-2-amine;
2-APB, 2-aminoethoxydiphenyl borate;
DDA, 2',5'-dideoxyadenosine;
PLC, phospholipase C;
DAG, diacylglycerol;
OAG, 1-oleoyl-2-acetyl-sn-glycerol;
SKF96365, 1-[
-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole;
TG, thapsigargin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berridge, M. J., Bootman, M. D., and Lipp, P. (1998) Nature 395, 645-648 |
| 2. | Putney, J. W., and Bird, G. S. (1993) Cell 75, 199-201 |
| 3. | Clapham, D. E. (1995) Cell 80, 259-268 |
| 4. | Parekh, A. B., and Penner, R. (1997) Physiol. Rev. 77, 901-930 |
| 5. | Putney, J. W., and McKay, R. R. (1999) Bioessays 21, 38-46 |
| 6. | Gill, D. L., Waldron, R. T., Rys-Sikora, K. E., Ufret-Vincenty, C. A., Graber, M. N., Favre, C. J., and Alfonso, A. (1996) Biosci. Rep. 16, 139-157 |
| 7. | Irvine, R. F. (1990) FEBS Lett. 263, 5-9 |
| 8. | Berridge, M. J. (1995) Biochem. J. 312, 1-11 |
| 9. | Patterson, R. L., van Rossum, D. B., and Gill, D. L. (1999) Cell 98, 487-499 |
| 10. | Putney, J. W. J. (1999) Cell 99, 5-8 |
| 11. | Yao, Y., Ferrer-Montiel, A. V., Montal, M., and Tsien, R. Y. (1999) Cell 98, 475-485 |
| 12. | Rosado, J. A., Jenner, S., and Sage, S. O. (2000) J. Biol. Chem. 275, 7527-7533 |
| 13. | Zhu, X., Jiang, M., Peyton, M., Boulay, G., Hurst, R., Stefani, E., and Birnbaumer, L. (1996) Cell 85, 661-671 |
| 14. | Montell, C. (1999) Annu. Rev. Cell Dev. Biol. 15, 231-268 |
| 15. | Kiselyov, K., Xu, X., Mohayeva, G., Kuo, T., Pessah, I. N., Mignery, G. A., Zhu, X., Birnbaumer, L., and Muallem, S. (1998) Nature 396, 478-482 |
| 16. | Kiselyov, K., Mignery, G. A., Zhu, M. X., and Muallem, S. (1999) Mol. Cell 4, 423-429 |
| 17. | Ma, H.-T., Patterson, R. L., van Rossum, D. B., Birnbaumer, L., Mikoshiba, K., and Gill, D. L. (2000) Science 287, 1647-1651 |
| 18. | Li, H. S., Xu, X. Z., and Montell, C. (1999) Neuron 24, 261-273 |
| 19. | Liu, X., Wang, W., Singh, B. B., Lockwich, T., Jadlowiec, J., O' Connell, B., Wellner, R., Zhu, M. X., and Ambudkar, I. S. (2000) J. Biol. Chem. 275, 3403-3411 |
| 20. | Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) Science 287, 1604-1605 |
| 21. | Louazo, C. M., Ribeiro, C. M. P., Bird, G., St, J., and Putney, J. W., Jr. (1996) J. Biol. Chem. 271, 14807-14813 |
| 22. | Ufret-Vincenty, C. A., Short, A. D., Alfonso, A., and Gill, D. L. (1995) J. Biol. Chem. 270, 26790-26793 |
| 23. | Favre, C. J., Ufret-Vincenty, C. A., Stone, M. R., Ma, H.-T., and Gill, D. L. (1998) J. Biol. Chem. 273, 30855-30858 |
| 24. | Ma, H.-T., Favre, C. J., Patterson, R. L., Stone, M. R., and Gill, D. L. (1999) J. Biol. Chem. 274, 35318-35324 |
| 25. | Ghosh, T. K., Mullaney, J. M., Tarazi, F. I., and Gill, D. L. (1989) Nature 340, 236-239 |
| 26. | Ghosh, T. K., Bian, J., and Gill, D. L. (1990) Science 248, 1653-1656 |
| 27. | Waldron, R. T., Short, A. D., and Gill, D. L. (1995) J. Biol. Chem. 270, 11955-11961 |
| 28. | Waldron, R. T., Short, A. D., and Gill, D. L. (1997) J. Biol. Chem. 272, 6440-6447 |
| 29. | Short, A. D., Klein, M. G., Schneider, M. F., and Gill, D. L. (1993) J. Biol. Chem. 268, 25887-25893 |
| 30. | Short, A. D., Bian, J., Ghosh, T. K., Waldron, R. T., Rybak, S. L., and Gill, D. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4986-4990 |
| 31. | Graber, M. N., Alfonso, A., and Gill, D. L. (1997) J. Biol. Chem. 272, 29546-29553 |
| 32. | Maruyama, T., Kanaji, T., Nakade, S., Kanno, T., and Mikoshiba, K. (1997) J. Biochem. (Tokyo) 122, 498-505 |
| 33. | Maruyama, T., Cui, Z., Kanaji, T., Mikoshiba, K., and Kanno, T. (1997) Biomed. Res. 18, 297-302 |
| 34. | Gafni, J., Munsch, J. A., Lam, T. H., Catlin, M. C., Costa, L. G., Molinski, T. F., and Pessah, I. N. (1997) Neuron 19, 723-733 |
| 35. | Guellaen, G., Mahu, J. L., Mavier, P., Berthelot, P., and Hanoune, J. (1977) Biochim. Biophys. Acta 484, 465-475 |
| 36. | Grupp, G., Grupp, I. L., Johnson, C. L., Matlib, M. A., Rouslin, W., Schwartz, A., Wallick, E. T., Wang, T., and Wisler, P. (1980) Br. J. Pharmacol. 70, 429-442 |
| 37. | Correia-de-Sa, P., and Ribeiro, J. A. (1994) Eur. J. Pharmacol. 271, 349-355 |
| 38. | Zitt, C., Obukhov, A. G., Strübing, C., Zobel, A., Kalkbrenner, F., Lückhoff, A., and Schultz, G. (1997) J. Cell Biol. 138, 1333-1341 |
| 39. | Zhu, X., Jiang, M., and Birnbaumer, L. (1998) J. Biol. Chem. 273, 133-142 |
| 40. | Hofmann, T., Obukhov, A. G., Schaefer, M., Harteneck, C., Gudermann, T., and Schultz, G. (1999) Nature 397, 259-263 |
| 41. | Rampe, D., Poder, T., Zhao, Z. Y., and Schilling, W. P. (1989) J. Cardiovasc. Pharmacol. 13, 547-556 |
| 42. | Merritt, J. E., Armstrong, W. P., Benham, C. D., Hallam, T. J., Jacob, R., Jaxa-Chamiec, A., Leigh, B. K., McCarthy, S. A., Moores, K. E., and Rink, T. J. (1990) Biochem. J. 271, 515-522 |
| 43. | Lee, H. R., Jaros, J. A., Roeske, W. R., Wiech, N. L., Ursillo, R., and Yamamura, H. I. (1985) J. Pharmacol. Exp. Ther. 233, 611-616 |
| 44. | Rampe, D., Triggle, D. J., and Brown, A. M. (1987) J. Pharmacol. Exp. Ther. 243, 402-407 |
This article has been cited by other articles:
![]() |
C. Zhang, T. A. Roepke, M. J. Kelly, and O. K. Ronnekleiv Kisspeptin Depolarizes Gonadotropin-Releasing Hormone Neurons through Activation of TRPC-Like Cationic Channels J. Neurosci., April 23, 2008; 28(17): 4423 - 4434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Essin, A. Welling, F. Hofmann, F. C. Luft, M. Gollasch, and S. Moosmang Indirect coupling between Cav1.2 channels and ryanodine receptors to generate Ca2+ sparks in murine arterial smooth muscle cells J. Physiol., October 1, 2007; 584(1): 205 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, H. H. Patel, F. Murray, C. V. Remillard, C. Schach, P. A. Thistlethwaite, Paul. A. Insel, and J. X.-J. Yuan Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1202 - L1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Hung and N. S. Magoski Activity-Dependent Initiation of a Prolonged Depolarization in Aplysia Bag Cell Neurons: Role for a Cation Channel J Neurophysiol, March 1, 2007; 97(3): 2465 - 2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Lanner, A. Katz, P. Tavi, M. E. Sandstrom, S.-J. Zhang, C. Wretman, S. James, J. Fauconnier, J. Lannergren, J. D. Bruton, et al. The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes, July 1, 2006; 55(7): 2077 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Cima, J. M. Dubach, A. M. Wieland, B. M. Walsh, and D. I. Soybel Intracellular Ca2+ and Zn2+ signals during monochloramine-induced oxidative stress in isolated rat colon crypts Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G250 - G261. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dobrydneva, C. J. Abelt, B. Dovel, C. M. Thadigiri, R. L. Williams, and P. F. Blackmore 2-Aminoethoxydiphenyl Borate as a Prototype Drug for a Group of Structurally Related Calcium Channel Blockers in Human Platelets Mol. Pharmacol., January 1, 2006; 69(1): 247 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, S. Mergler, X. Sun, Z. Wang, L. Lu, J. A. Bonanno, U. Pleyer, and P. S. Reinach TRPC4 Knockdown Suppresses Epidermal Growth Factor-induced Store-operated Channel Activation and Growth in Human Corneal Epithelial Cells J. Biol. Chem., September 16, 2005; 280(37): 32230 - 32237. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Egan, C. L. Wainwright, R. M. Wadsworth, and G. F. Nixon PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca2+ regulation Cardiovasc Res, August 1, 2005; 67(2): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-P. He, T. Hewavitharana, J. Soboloff, M. A. Spassova, and D. L. Gill A Functional Link between Store-operated and TRPC Channels Revealed by the 3,5-Bis(trifluoromethyl)pyrazole Derivative, BTP2 J. Biol. Chem., March 25, 2005; 280(12): 10997 - 11006. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dong, Z. M. Sellers, A. Smith, J. Y. C. Chow, and K. E. Barrett Na+/Ca2+ exchange regulates Ca2+-dependent duodenal mucosal ion transport and HCO3- secretion in mice Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G457 - G465. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Slice, T. Chiu, and E. Rozengurt Angiotensin II and Epidermal Growth Factor Induce Cyclooxygenase-2 Expression in Intestinal Epithelial Cells through Small GTPases Using Distinct Signaling Pathways J. Biol. Chem., January 14, 2005; 280(2): 1582 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. J. Hoenderop, B. Nilius, and R. J. M. Bindels Calcium Absorption Across Epithelia Physiol Rev, January 1, 2005; 85(1): 373 - 422. [Abstract] [Full Text] [PDF] |